Animals fed heat-killed HT115 have an impaired phenotype after anoxia treatment. by Bobby L. LaRue (231047)

“…<p>N2 adult hermaphrodites were fed either the OP50 or HT115 <i>E. coli</i> strain, raised at 25°C, transferred to heat-killed OP50 or HT115 and exposed to either three days (A) or four days of anoxia (B). …”

<i>Concatenated</i> ML tree. by Jana Kvičerová (430538)

Median phyla frequencies under conditions of LSG and HSG. by J. Max Goodson (469397)

Hydrogen peroxide (H2O2) improves ion homeostasis in coriander plants under salt stress by Petterson C. C. Silva (16477302)

“…The coriander plants were grown in nutrient solutions without presence of NaCl for control treatment (T1), while the other five treatments received 50 mM NaCl: T2 (absence of H2O2 in seed pretreatment), T3, T4, T5, and T6 corresponding to seed pretreatment with H2O2 at concentrations of 0.1, 1, 10, and 100 mM, respectively, in a completely randomized design with four replicates. …”

ACA reduced expression of Th2 and Th1 cytokines in OVA-induced asthma. by Joung-Wook Seo (381837)

“…(c) ACA also decreased IL-5 expression but to a lesser extent. (d) ACA almost completely blocked IL-12α expression and (e) downregulated IFN-γ expression. …”

Comparison of the number of immune cells in ovarian follicles determined by morphometric analysis. by Michael J. Bradaric (456157)

“…Three sections from each ovary for each hen were counted at a magnification of 20x; scale bar = 50 µm. Error bars represent mean ± SEM.…”

Microwave signals of 3D skin models at different osmolalities. by Rico Brendtke (2591161)

“…All scale bars indicate 50 μm. Bar diagrams show mean values, error bars depict standard deviation. …”

Fibrotic changes in the murine lungs and livers of the DMSO, valsartan, and PD123319 groups. by Saori Yaguchi (418831)

“…E: The fibrosis was thinnest in the valsartan group (p<0.01). Magnification, A: X200. Scale bar, A: 50 µm. The results represent the mean ± SD. …”

Table_1_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc... by Miguel J. Gil-Gil (3074085)

“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”

DataSheet_2_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast... by Miguel J. Gil-Gil (3074085)

“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”

Table_1_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc... by Miguel J. Gil-Gil (3074085)

“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”

Table_2_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc... by Miguel J. Gil-Gil (3074085)

“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”

DataSheet_2_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast... by Miguel J. Gil-Gil (3074085)

“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”

Table_3_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc... by Miguel J. Gil-Gil (3074085)

“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”

Table_3_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc... by Miguel J. Gil-Gil (3074085)

“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”

DataSheet_1_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast... by Miguel J. Gil-Gil (3074085)

“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”

Table_2_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc... by Miguel J. Gil-Gil (3074085)

“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”

DataSheet_1_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast... by Miguel J. Gil-Gil (3074085)

“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”

Evaluation of HH target gene mRNA and protein expression following vismodegib treatment of canine OSA cell lines. by Vincent E. Baldanza (8781671)

“…<p>(A) The cell lines demonstrated variable decreases in some target genes at the transcript level with treatment at the determined IC₅₀ value when compared to vehicle control (DMSO) treatment. …”

Supplementary Material for: Online Tool (Brain Assessment) for the Detection of Cognitive Function Changes during Aging by Satoh M. (7427648)

“…We standardized the raw scores (cognitive scores, CSs) using mean and standard deviation, which were 50 and 10, respectively. …”